emka TECHNOLOGIES, now joined with SCIREQ, has been providing integrated systems for preclinical physiology, pharmacology and toxicology research for over 20 years.

Our hardware and software are used daily, validated by major pharma companies and CROs and cited in over 2,000 peer-reviewed scientific publications.

emka TECHNOLOGIES offers systems for cardiovascular, respiratory and neurological studies, to meet S7A and S7B requirements and 3 R's guiding principle (Replacement, Reduction and Refinement of animal use in preclinical research).

Our in vitro models can be used in place of whole animals, we offer a wide variety of systems for studying different types of tissues, to enhance replacement.

Most of our systems are designed to offer a wide range of parameters so you get maximum information from each animal. With real-time analysis, any required adjustments can be made immediately, and experiments are not wasted. With our non-invasive solutions, animals can be used as their own controls over a long period of time, reducing data variance and consequently the number of animals needed per treatment group.

Finally, telemetry technology to acquire physiological parameter minimize stress and enhance animal welfare, to improve refinement.